Cognition Therapeutics Inc (CGTX) Company Profile & Statistics

Cognition Therapeutics Inc
CGTX
(Nasdaq - US)
Closed
0.49
+0.02 (+3.81%)
in:usd•As of: Nov 05, 2024 12:23 UTC -5
Open
0.48
High
0.50
Low
0.48

About Cognition Therapeutics Inc

CEO

Lisa Ricciardi

Headquarters

2500 westchester avenue

purchase, ny 10577, united states

Auditor

Ernst & Young LLP

Employees

Share Holders

277

Website

www.cogrx.com

Industry

biotechnology

Sector

health technology

Company Overview

Cognition Therapeutics Inc.is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Cognition Therapeutics Inc.is based in PURCHASE, N.Y.

Cognition Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	19.76M
Enterprise Value	-8.77M
Enterprise Value/EBITDA (ttm)	0.15
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.82
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-118.11%
Return on Invested Capital (ttm)	-118.91%
Return on Assets (ttm)	-84.49%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-58.46M
Net Income Avi to Common (ttm)	-31.08M
Diluted EPS (ttm)	-0.94

Share Statistics

Beta (5Y Monthly)	1.34
52-Week Change	-53.54%
S&P500 52-Week Change	32.45%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	40.13M
Dividend Yield	0.00%
Float ⁴	31.80M
% Held by Insiders	20.75%
% Held by Institutions	43.35%

Balance Sheet

Total Cash (mrq)	28.53M
Total Cash Per Share (mrq)	0.71
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	3.07%
Quick Ratio (mrq)	3.07%
Book Value Per Share (mrq)	0.57

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.33
Free Cash Flow (ytd)	-13.24M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Cognition Therapeutics Inc

Trade With A Regulated Broker